Summary of CYCLACEL PHARMACEUTICALS, INC.

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

CYCC > SEC Filings for CYCC > Form 8-K on 13-Jan-2009

All Recent SEC Filings

Show all filings for CYCLACEL PHARMACEUTICALS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for CYCLACEL PHARMACEUTICALS, INC.

13-Jan-2009

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On January 13, 2009, Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the "Company"), issued a press release announcing that the Company has begun a Phase 2 clinical trial of oral sapacitabine (CYC682) in patients with previously treated, non-small cell lung cancer.

The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Number Description
99.1 Press release, dated January 13, 2009

Add CYCC to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for CYCC - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.